A certificate under section 57B(4) of the Act must, in addition to a statement as to the presence of a prescribed illicit drug in that sample of oral fluid, contain the following particulars—
(a) a statement by the analyst that he or she is an approved analyst within the meaning of section 57B of the Act; and
(b) a statement as to the method of analysis used; and
(c) the name and signature of the analyst; and
(d) the date on which the analysis was conducted; and
(e) a description of the contents of the identification label referred to in regulation 19 that was attached to the part of the oral fluid received for analysis.